Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2024-11-08 | 2025-05-08 | 242344 |
| TEVA-CLONIDINE | 0.2MG | TABLET | Resolved | 2025-01-23 | 2025-05-08 | 248427 |
| TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2020-03-26 | 2020-04-09 | 109623 |
| TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2022-08-18 | 2022-09-08 | 167191 |
| TEVA-CLONIDINE | 0.2MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195888 |
| TEVA-CLONIDINE | 0.025MG | TABLET | Actual shortage | 2023-10-05 | 2024-07-03 | 206416 |
| TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2020-07-30 | 2020-08-21 | 121503 |
| TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2022-12-08 | 2023-01-26 | 177520 |
| TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183364 |
| TEVA-CLONIDINE | 0.2MG | TABLET | Resolved | 2023-02-16 | 2023-10-04 | 184946 |
| TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2021-08-13 | 2021-10-07 | 144108 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-02 | 2022-01-20 | 145124 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-30 | 2022-01-20 | 146446 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-01-27 | 2022-11-12 | 153733 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-09-24 | 2020-11-26 | 124968 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2020-12-17 | 126912 |
| TEVA-CLOPIDOGREL | 300MG | TABLET | Resolved | 2020-10-22 | 2020-10-30 | 126915 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-22 | 2021-04-21 | 126942 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-06-19 | 2023-10-06 | 195566 |
| TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-06-20 | 2023-10-06 | 195803 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253165 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240081 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
| TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253182 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81313 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253160 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
| TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
| TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
| TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |